Loading company…
Toll Biotech develops drugs for autoimmune diseases and other conditions.
Toll Biotech conducts drug research and development, with a focus on autoimmune diseases. Its platforms cover drug discovery, preclinical development and clinical development, and its pipeline includes potential applications in rheumatoid arthritis, lupus, viral infections and Parkinson's. Established in 2020, the company is based in Beijing and has collaborations with Tsinghua University, Peking University and the Chinese Academy of Sciences.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in